Clidinium
Librax, Quarzan (clidinium) is a small molecule pharmaceutical. Clidinium was first approved as Librax on 1982-01-01. It is used to treat inflammatory bowel diseases and peptic ulcer in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
digestive system diseases | D004066 |
Trade Name
FDA
EMA
Combinations
Librax (generic drugs available since 2020-07-07)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
chlordiazepoxide hcl and clidinium bromide | ANDA | 2023-04-26 |
librax | New Drug Application | 2021-02-03 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
inflammatory bowel diseases | EFO_0003767 | D015212 | — |
peptic ulcer | HP_0004398 | D010437 | K27 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
14 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | 3 | 1 | — | — | 4 |
Dermatitis | D003872 | HP_0011123 | L30.9 | — | — | 2 | — | — | 2 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | 1 | — | — | 2 |
Ocular motility disorders | D015835 | EFO_1001990 | H50.54 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | 1 | 2 | — | — | — | 2 | |
Angioedema | D000799 | EFO_0005532 | T78.3 | — | 1 | — | — | — | 1 |
Chronic urticaria | D000080223 | L50.8 | — | 1 | — | — | — | 1 | |
Optic neuritis | D009902 | EFO_0007405 | H46 | — | 1 | — | — | — | 1 |
Chronic progressive multiple sclerosis | D020528 | 1 | 1 | — | — | — | 1 | ||
Sclerosis | D012598 | 1 | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CLIDINIUM |
INN | clidinium bromide |
Description | Clidinium is the ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. It has a role as a parasympatholytic, an antispasmodic drug and an anti-arrhythmia drug. It is a quaternary ammonium ion, a carboxylic ester and an organic cation. It is functionally related to a benzilic acid and a 3-quinuclidinol. |
Classification | Small molecule |
Drug class | quaternary ammonium derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2 |
Identifiers
PDB | — |
CAS-ID | 7020-55-5 |
RxCUI | 21232 |
ChEMBL ID | CHEMBL620 |
ChEBI ID | — |
PubChem CID | 2784 |
DrugBank | DB00771 |
UNII ID | 91ZQW5JF1Z (ChemIDplus, GSRS) |
Target
Agency Approved
Alternate
CHRM2
CHRM2
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 181 documents
View more details
Safety
Black-box Warning
Black-box warning for: Chlordiazepoxide hcl and clidinium bromide
, Librax
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
670 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more